Gerald Winkels

HeartFlow, Inc. operates as a cardiovascular company which engages in diagnosing coronary artery diseases. The firm provides a patient-specific analysis of coronary blood flow utilizing coronary CT scans and proprietary computer algorithms based on computational fluid dynamics. The company was founded by Charles A. Taylor, Nathan M. Wilson, and Christopher K. Zarins in 2007 and is headquartered in Redwood City, CA.

HealthCor Partners Fund LP invests in companies located in the US. The fund targets the companies operating in the fields of healthcare and life sciences. The fund provides financing in the form of equity and debt for restructurings, recapitalizations, later stage requirements, buyouts , acquisitions and other special situations with an investment size ranges between $5 million to $25 million in each portfolio company . The fund makes minority and/or control investments. The fund also invests in public companies.

IASIS Healthcare LLC owns and operates acute care hospitals. It operates business through two segments: Acute Care and Health Choice. The Acute Care segment comprises of its hospitals, outpatient service facilities and physician clinics which offers a variety of medical and surgical services commonly available in hospitals, including emergency services, general surgery, internal medicine, cardiology, obstetrics, orthopaedics, psychiatry and physical rehabilitation. The Health Choice segment is a provider-owned, managed care organization and insurer. The company was founded in 1998 and is headquartered in Dallas, TX.

Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY.

IASIS Healthcare Corp. owns and operates community-focused hospitals. The company was founded in September 1994 and is headquartered in Dallas, TX.

HealthCor Group LLC provides investment advisory services to private investment funds. The company is headquartered in New York, NY.

Access Closure, Inc. manufactures and distributes medical devices for cardiovascular and peripheral vascular markets. Its products include Mynx ace, Mynx grip, Mynx sealant technology and flash ostial system. The company was in founded in 2002 by Farhad Khosravi and is headquartered in Santa Clara, CA.

Cordis Corp. develops and manufactures devices for interventional vascular medicine and electrophysiology. The firm's products include guidewires, balloons, forceps, catheters, and stents to treat a variety of circulatory system problems including coronary artery disease and cerebral aneurysms. The company was founded by William P. Murphy Jr. in 1959 and is headquartered in Milpitas, CA.

HealthCor Partners Fund II LP invests primarily in later-stage developmental and growing (private or publicly traded) mid-sized companies across all sectors of the healthcare and life sciences industry. The fund makes minority and controlling investments. It backs experienced management teams in leveraged buyouts and in creating growing companies through a series of acquisitions. It also selectively invests in restructurings, recapitalizations and other special situations involving more established healthcare companies. It makes equity and equity related investments between USD 5 - 25 million in each portfolio company.

HealthCor Partners Management LP (HealthCor Partners) is a private equity subsidiary of HealthCor Group LLC founded in 2007 by Michael Yehuda Mashaal, Arthur Bruce Cohen and Joseph Patrick Healey. The firm is headquartered in New York.

Amplitude Vascular Systems, Inc. develops technology for healthcare services. The company is headquartered in Ann Arbor, MI.

De Heus Animal Nutrition BV engages in the development and supply of nutritional products for animals. It also provides animal nutrition and animal husbandry services. The company was founded by Hendrik Antonie de Heus on April 28, 1911 and is headquartered in Ede, The Netherlands.

Koninklijke De Heus BV operates as a financial holding company with interests in the manufacture and distribution of animal feeds. The company was founded by Hendrik Anthonie de Heus on April 28,1911 and is headquartered in Ede, the Netherlands.

Van Hessen BV processes and distributes natural sausage casings. Its products include natural casing, pharmaceutical products and animal by-products. The company was founded by Ludwig Van Hessen in 1902 and is headquartered in Nieuwerkerk aan den IJssel, the Netherlands.

INCOTEC is the world-wide leader in adding value to seed and other starter materials through various seed and coating technology methods. Incotec is active in the markets vegetables, flowers, tobacco and large field crop. INCOTEC may improve plantability and seed emergence through technologies such as pelleting, film coating, priming, upgrading and disinfection against seedborne diseases.

Refresco Holding BV operates as a financial holding company with interests in the fruit juice and soft drink industry. The company was founded on March 30, 2000 and is headquartered in Rotterdam, the Netherlands.

Ploeger Oxbo Group BV engages in the manufacture and sale of agricultural harvesting equipment for the processing industry and fresh market. Its products include peas, green beans, potatoes, carrots, spinach, berries, citrus, coffee, grapes, olives, and sweet corn. Its brands include Bourgoin, BCMH, Oxvo, Korvan, Pixall, Ploeger, and PMC. The company was founded in 2011 and is headquartered in Roosendaal, the Netherlands.

Hendrix Genetics BV is a multi-species animal breeding, genetics, and technology company, which engages in the breeding programs of breeding programs in turkeys, layers, guinea fowl, swine, salmon, and trout. The company was founded by Antoon van den Berg and Thijs Hendrix in 1923 and is headquartered in Boxmeer, the Netherlands.

Visa International, Inc. provides credit card services. The company was founded by Dee Hock and is headquartered in Foster City, CA.

Portigon AG engages in the management of its own assets. It also provides financial services and conducts banking activities. The company was founded in 1969 and is headquartered in Duesseldorf, Germany.

Raiffeisenbank JSC (Broker) (Raiffeisenbank-Broker) is the broker-dealer division of Raiffeisenbank AO, which is owned by Raiffeisen Bank International AG (VIE: RBI; OTCMKTS: RAIFY) in Austria. Headquartered in Moscow, Raiffeisenbank-Broker was founded in 1996 and provides execution services to various clients.

Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT.

The Brigham & Women's Hospital, Inc. provides health care services. The firm offers treatment for cancer, cardio vascular, neurosciences, orthopedic, arthritis, women's health and clinical services. The company was founded in 1980 and is headquartered in Boston, MA.

CBSET, Inc. is a not-for-profit biomedical research institute located in Lexington, MA. The non-profit company's mission is to advance biomedical research through innovative, high-quality preclinical services to achieve the scientific, regulatory, and commercial goals of its sponsors. CBSET combines top-tier research with operational expertise by providing in vivo studies, in vitro studies, computational and 3D modeling, and complex histopathology services. The company's 40,000-foot, GLP-compliant, OLAW-assured, AAALAC-accredited facility includes vivaria, procedure rooms, catheterization/imaging labs, surgical and necropsy suites, histopathology, SEM, and a range of other technologies.

InspireMD Ltd. is a medical device company, which engages in the development and commercialization of platform technology for the treatment of vascular and coronary disease. It offers MicroNet stent, a device designed to trap and seal thrombus and plaque against the vessel wall, preventing embolization. The company was founded in 2005 and is headquartered in Tel Aviv, Israel.

EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA.